Patent AnalyticsExaminers
Rankings

Company or institution

Stemline Therapeutics, Inc.

36 applicationsfiled 2007 to 2024

Allowance rate
39%
−36 pts vs the USPTO range 25% to 56%
Rejections before allowance
1.9
+0.3 vs the USPTO
Months to first action
18.7 mo
level with the USPTO
Needed an RCE
27%
level with the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations19 apps
C07K Peptides8 apps
G01N Investigating or analysing materials7 apps
C12N Microorganisms or enzymes2 apps

Art units

16479 apps
16747 apps
16465 apps
16434 apps
16423 apps
16352 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
18958835IL3Ra Antibody Conjugates and Uses Thereof2024-11-25Pending00n/a
18936653Improved Lyophilized Formulation2024-11-04Pending00n/a
18626722Inhibitors of Mutant RET Kinases for use in Treating Cancer2024-04-04Pending1024.5 mo
15662725Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15708389Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15392252Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15723591Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15865904Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15666019Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15184190Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 36 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in